Antimicrobial stewardship in patients with confirmed coronavirus disease 2019 (COVID-19).

Sarah E MooreAshley M WildeBrian C BohnMatthew SongPaul Schulz

Published in: Infection control and hospital epidemiology (2021)

Hospitalized coronavirus disease 2019 (COVID-19) patients receiving antibiotics (n = 173) were retrospectively assigned to the early or late discontinuation groups. The length of therapy was shorter in the early discontinuation group (3 vs 7 days; P < .0001). Mortality rates (14.3% vs 20.7%; P = .316) and length of stay (7 vs 9 days; P = .063) were similar.

Keyphrases

coronavirus disease
respiratory syndrome coronavirus
sars cov
risk factors
mesenchymal stem cells